SGLT2 inhibitors - inpatient use

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 10/22/2025 - 17:25
#1
Alexandra Perreiter
Alexandra Perreiter's picture
Offline
Last seen: 8 hours 34 min ago
Joined: 02/22/2018 - 14:29
SGLT2 inhibitors - inpatient use

Hi Everyone,
Wanted to see if any of you have good workflow processes (including EMR configurations) to ensure that any patient who receives an SGLT2 inhibitor inpatient does not receive this medication as their condition may change, like becoming NPO, unplanned procedure, abnormal labs, etc.. Are you storing this medication in your ADC and relying on your nurses to hold if needed, or are your pharmacists actively involved in a daily review or other strategies?
Really appreciate any insights, and hearing what may work well at your respective hospitals.
Thank you! Alex

Top